Medistim ASA - Asset Resilience Ratio
Medistim ASA (MEDI) has an Asset Resilience Ratio of 29.72% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2021)
This chart shows how Medistim ASA's Asset Resilience Ratio has changed over time. Check MEDI PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Medistim ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Medistim ASA (MEDI) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr183.45 Million | 29.72% |
| Short-term Investments | Nkr0.00 | 0% |
| Total Liquid Assets | Nkr183.45 Million | 29.72% |
Asset Resilience Insights
- Very High Liquidity: Medistim ASA maintains exceptional liquid asset reserves at 29.72% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Medistim ASA Industry Peers by Asset Resilience Ratio
Compare Medistim ASA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for Medistim ASA (2016–2021)
The table below shows the annual Asset Resilience Ratio data for Medistim ASA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 32.11% | Nkr129.49 Million ≈ $13.63 Million |
Nkr403.24 Million ≈ $42.43 Million |
+11.32pp |
| 2020-12-31 | 20.79% | Nkr71.89 Million ≈ $7.57 Million |
Nkr345.82 Million ≈ $36.39 Million |
+0.93pp |
| 2019-12-31 | 19.86% | Nkr66.75 Million ≈ $7.02 Million |
Nkr336.11 Million ≈ $35.37 Million |
+2.24pp |
| 2018-12-31 | 17.62% | Nkr47.49 Million ≈ $5.00 Million |
Nkr269.59 Million ≈ $28.37 Million |
-4.06pp |
| 2017-12-31 | 21.67% | Nkr54.41 Million ≈ $5.73 Million |
Nkr251.06 Million ≈ $26.42 Million |
+7.36pp |
| 2016-12-31 | 14.31% | Nkr31.07 Million ≈ $3.27 Million |
Nkr217.05 Million ≈ $22.84 Million |
-- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more